Poly Medicure POLYMED
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Poly Medicure's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
AI analysis and Advanced tools for POLYMED
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,918.57 | 3,192.45 | 1,858.67 |
| Cash Equivalents | 36.64 | Not available | Not available |
| Other Liabilities Total | 78.58 | 12.99 | 9.72 |
| Long Term Debt | 52.09 | 0 | 1.09 |
| Common Stock Total | 50.68 | 50.66 | 47.99 |
| Other Current Assets Total | 103.45 | 1.05 | 2.58 |
| Total Assets | 3,918.57 | 3,192.45 | 1,858.67 |
| Current Portof LT Debt/Capital Leases | 296.33 | 4.77 | 20.07 |
| Cash | 51.23 | 8.7 | 12.05 |
| Total Equity | 3,106.17 | 2,765.66 | 1,470.05 |
| Long Term Investments | 34.38 | 20.51 | 28.15 |
| Retained Earnings(Accumulated Deficit) | 3,055.49 | 1,334.9 | 1,025.63 |
| Total Common Shares Outstanding | 10.14 | 10.13 | 9.6 |
| Tangible Book Valueper Share Common Eq | 263.13 | 267.5 | 147.59 |
| Goodwill Net | 273.79 | 28.58 | 28.58 |
| Total Liabilities | 812.39 | 426.79 | 388.62 |
| Total Debt | 353.58 | 180.25 | 174.15 |
| Short Term Investments | 784.66 | 1,201.53 | 280.28 |
| Cashand Short Term Investments | 872.53 | 1,210.22 | 292.33 |
| Total Receivables Net | 531.92 | 416.63 | 322.52 |
| Deferred Income Tax | 57.97 | 42.87 | 24.48 |
| Accounts Receivable-Trade Net | 531.17 | 353.96 | 274.26 |
| Property/Plant/Equipment Total-Net | 1,353.62 | 1,130.2 | 888.94 |
| Minority Interest | 43.07 | Not available | Not available |
| Total Current Liabilities | 575.52 | 370.17 | 351.24 |
| Total Inventory | 433.84 | 285.57 | 221.03 |
| Accounts Payable | 122.67 | 86.42 | 95.6 |
| Other Currentliabilities Total | 156.53 | 59.93 | 84.54 |
| Total Long Term Debt | 57.25 | 0.77 | 3.18 |
| Intangibles Net | 165.3 | 26.61 | 24.99 |
| Other Long Term Assets Total | 149.75 | 20.59 | 13.82 |
| Total Current Assets | 1,941.73 | 1,917 | 841.63 |
| Capital Lease Obligations | 5.16 | 0.77 | 2.09 |
| Accumulated Depreciation Total | Not available | -486.12 | -421.34 |
| Accrued Expenses | Not available | 44.35 | 0.12 |
| Other Equity Total | Not available | 1.76 | 3.11 |
| Prepaid Expenses | Not available | 3.52 | 3.16 |
| Additional Paid-In Capital | Not available | 1,378.34 | 393.33 |
| Property/Plant/Equipment Total-Gross | Not available | 1,526.67 | 1,243.58 |
| Notes Payable/Short Term Debt | Not available | 174.7 | 150.91 |
| Note Receivable-Long Term | Not available | 48.96 | 32.56 |
Valuation and ratios
Valuation
PEG Ratio2.78
Price to Sale Ratio9.20
Growth
Debt 5Yr CAGR %20.8
Margins
Operating Margin 12m17.09
Operating Margin 5y Avg19.51
Net Profit Margin 12m17.1
Net Profit Margin 5y17.87
Yield
Dividend Yield %0.2
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk46.91
Analyst consensus
ConsensusHold
Consensus score2.60
Analyst opinions5
Strong Sell count0
Sell count1
Hold count2
Buy count1
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Lenskart Solutions | INR 565.7 | 98,565.99 | 181 | — |
| Laxmi Dental | INR 216.7 | 1,197.04 | 35.63 | — |
| Mallcom (India) | INR 1,022 | 637.72 | 21.91 | — |
| One Global Service Provider | INR 567 | 1,108.09 | 16.95 | — |
| Hemant Surgical Industries | INR 365 | 530.62 | 26.04 | — |
Ownership
- Promoter
- 62.42%
- FII
- 5.56%
- MF
- 9.61%
- Other
- 22.41%
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Poly Medicure Investing In Facilities And Products To Double International Sales Sahi
Poly Medicure bets on new facilities, products to double international business: MD The Economic Times
Delhi HC stays stamp duty order against Poly Medicure scanx.trade
Poly Medicure among 4 stocks that closed below VWAP The Economic Times
Poly Medicure - Positive Breakout: These 8 stocks cross above their 200 DMAs The Economic Times
Poly Medicure Targets 20% Domestic Growth and 16% International Revenue Hike in FY26 Sahi
Events
- board MeetingsQuarterly Results
- dividendRs.3.5000 per share(70%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.3.5000 per share(70%)Final Dividend
- board MeetingsTo consider other business matters.
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- board MeetingsTo consider other business matters.
- annual General MeetingPOM
- board MeetingsQuarterly Results & ESOP
- annual General MeetingRs.3.0000 per share(60%)Final Dividend & A.G.M.
- dividendRs.3.0000 per share(60%)Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsInter alia, to consider and finalize the terms and condition and approve the modes of fund raising.
- board MeetingsAudited Results & Final Dividend
- board MeetingsInter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s).
Discussion and sentiment for Poly Medicure
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Community discussion loads as you approach this section.
Business information
What the company does
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Company facts
- Industry
- Medical Equipment & Supplies
- Sector
- Medical Equipment & Supplies
- NSE Code
- POLYMED
- BSE Code
- 531768
Stock FAQ
What is the symbol and ISIN of Poly Medicure?
Poly Medicure has the symbol POLYMED and ISIN - INE205C01021.
What is the latest recorded price of Poly Medicure?
The latest available recorded price of Poly Medicure is INR 1,709.30 as of 2026-08-06T20:54:51.459Z. This is a source-stamped snapshot, not a live quote.
What are the year high and year low of Poly Medicure?
Year high: INR 2,143.60. Year low: INR 1,184.00.
What is the market capitalization of Poly Medicure?
Market capitalization: INR 17,256.49 crore.
What is the P/E ratio of Poly Medicure?
P/E ratio: 37.47.
What is the dividend yield of Poly Medicure?
Dividend yield: 0.20%.
How is the financial performance of Poly Medicure based on revenue, net income, and EPS?
Revenue: INR 1,875.26 crore. Net income: INR 322.14 crore. EPS: INR 32.24.
What is the book value of Poly Medicure?
Book value: INR 263.13.
What are the price-to-book and price-to-sales ratios of Poly Medicure?
Price-to-book ratio: 6.50. Price-to-sales ratio: 9.20.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.

